21 CFR 1317.85 - Ultimate user delivery for the purpose of recall or investigational use of drugs

Cite as21 CFR 1317.85
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
3 practice notes
  • Disposal of Controlled Substances
    • United States
    • Federal Register December 21, 2012
    • December 21, 2012
    ...users in lawful possession of Schedule I substances for investigational use, DEA proposes that they follow the disposal procedures in 21 CFR 1317.85(b). Furthermore, the proposed collection methods are intended for the collection and destruction of lawfully possessed controlled substances, ......
  • Disposal of Controlled Substances
    • United States
    • Federal Register September 09, 2014
    • September 9, 2014
    ...in an investigational use of drugs pursuant to 21 U.S.C. 355(i) and 360b(j), and the delivery is conducted in accordance with 21 CFR 1317.85. Collection Receptacle Placement and 19 Issue: Ten commenters expressed concern regarding security in retail pharmacies with collection receptacles. S......
  • Management Standards for Hazardous Waste Pharmaceuticals
    • United States
    • Federal Register September 25, 2015
    • September 25, 2015
    ...or containers. \81\ DEA controlled substances can be returned to a long-term care pharmacy only if they are subject to a recall (see 21 CFR 1317.85(a)). \82\ See notes from 11-15-12 site visit to Omnicare, Inc. in the docket for this proposed rule \83\ Due to the DEA regulations, a DEA regi......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT